The effect of mepolizumab on patients with nasal polyp eosinophilia

Trial Profile

The effect of mepolizumab on patients with nasal polyp eosinophilia

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs Mepolizumab (Primary)
  • Indications Nasal polyps; Rhinosinusitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Mar 2018 Planned End Date changed from 30 Sep 2018 to 21 Feb 2021.
    • 16 Mar 2018 Planned initiation date changed from 20 Feb 2018 to 16 Apr 2018.
    • 30 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top